Chemical and Pharmaceutical Bulletin p. 184 - 193 (2000)
Update date:2022-09-26
Topics:
Okada, Yoshio
Matsumoto, Yoshikazu
Tsuda, Yuko
Tada, Mayako
Wanaka, Keiko
Hijikata-Okunomiya, Akiko
Okamoto, Shosuke
Various compounds were synthesized by combining three components at positions P1, P1, and P2,. Of these, N-(trans-4- aminomethylcyclohexanecarbonyl)-Tyr(O-2-bromobenzyloxycarbonyl)-octylamide inhibited plasmin selectively with IC50 values of 0.80 and 0.23 μM towards S-2251 and fibrin, respectively. This compound also inhibited plasma kallikrein, urokinase, thrombin and trypsin with IC50 values of 10, >50, >50 and 1.6 μM, respectively.
View MoreShandong Wanda Organosilicon New Material Co., Ltd
Contact:+86-21-54177116;54302881
Address:R1318 Greenland No. 3 Lane 58 Xinjian East Rd., Minhang
Jinzhou Jiutai Pharmaceutical Co.,Ltd
Contact:+86-0416-5179890
Address:No.41, Taianli, Taihe District, Jinzhou, Liaoning
Jiangsu King Road New Materials Co., Ltd.
website:http://www.jskingroad.com
Contact:0519-85720726 0519-85720721 13584535752
Address:No.1,Weihua Road,Xinbei District,Changzhou City,Jiangsu Province
ChangZhou Mascotchem. Co.,Ltd.
website:http://www.mascotchem.com
Contact:86-519-85010339
Address:B-802,XingBei Building,391#,Tongjiang Middle Road New District,Changzhou,JS,China
Changzhou BaoKang Pharmaceutical & Chemical Co., Ltd
Contact:(86) 519-88782201 88784080 88785278
Address:Henglin town, changzhou,Jiangsu
Doi:10.1021/ja01349a029
(1932)Doi:10.1080/00397910008087117
(2000)Doi:10.1021/jo00803a026
(1971)Doi:10.1016/j.tetasy.2016.11.007
(2017)Doi:10.1016/j.poly.2012.06.079
(2013)Doi:10.1021/om400130m
(2013)
